Il Dipartimento di Medicina Molecolare organizza l'incontro annuale di confronto con i dottorandi della scuola di dottorato in Translational and Precision Medicine.

Vedere il file PDF allegato peril programma della giornata.

Il Consiglio di Dipartimento del mese di maggio è convocato per il giorno 27 maggio a partire dalle ore 15:00.

Il Dipartimento di Medicina Molecolare è lieto di invitarvi al seminario della Dott.ssa Giada Bianchi, MD, intitolato:

Thinking Outside the B(oT)ox for the Treatment of AL Amyloidosis

Il seminario si terrà il giorno 11 giugno 2025, a partire dalle ore 14:30, presso l'aula 1.11 del Campus della Salute.

The Department of Molecular Medicine is pleased to invite you to the seminar by Prof. Lorenzo Puri, titled:

"Epigenetic control of skeletal muscle in health and disease: identification of HDAC inhibitors for treatment of Duchenne Muscular Dystrophy"

The seminar will take place on March 20, starting at 3 PM, in "Aula Mosca", Via Forlanini 18.

For further information, please contact Prof. Roberto Bottinelli.

Biosketch:

Pier Lorenzo Puri earned his MD at the University of Rome “la Sapienza” in 1991. Dr. Puri completed his internship in Internal Medicine at the hospital “Policlinico Umberto I” (Rome) from 1992 to 1997, and defended an experimental thesis on the vascular effects of angiotensin II to graduate as Specialist in Internal medicine at the University of Rome “la Sapienza” in 1997. During this time he was frequently working at the Freien University of Berlin, as visiting scientist at the Deprtment of Biochemistry and Molecular Biology, to perform experiments of protein and DNA microinjection in cultured cells. Dr. Puri trained as a post-doctoral fellow at the University of California San Diego (UCSD), in the department of Cell Biology, under the supervision of Dr. Wang, from 1997 to 2001. He was appointed as Staff Scientist at the Salk Institute (La Jolla) in 2001, and became an Assistant Telethon Scientist at the Dulbecco Telethon Institute in Rome in 2002. He was upgraded to Associate Telethon Scientist at the Dulbecco Telethon Institute in Rome since 2007 and became Senior Telethon Scientist, Dulbecco Telethon Institute, in 2012, but declined this position. Dr. Puri joined Sanford Burnham Prebys as an Assistant Professor in 2004. He has been promoted to Associate Professor in 2010 and full Professor in 2015. From 2008 to 2016 Dr. Puri served as Adjunct Professor of Pediatrics at the University of California, San Diego. From 2008 to 2013 Dr Puri was an Associate Member of Sanford Children’s Health Research Center. Dr Puri has been Director of the laboratory of Epigenetics and Regeneration at Fondazione S. Lucia, Roma, Italy, but stepped down this position since 2019.

Dalle ore 9 alle ore 14 sarà possibile votare per l'elezione del Direttore del Dipartimento di Medicina Molecolare, secondo le modalità descritte nell'apposita pagina dedicata.

Il Dipartimento di Medicina Molecolare è lieto di invitarvi a partecipare al seminario del Prof. del Prof. Sébastien Jaillon (Humanitas University), intitolato:

"Unveiling the role and dynamics of neutrophil-dependent immune response in cancer"

Il seminario si terrà presso l'aula seminari dell'unità Golgi/Spallanzani (auletta di patologia generale), alle ore 15:30 del giorno 11 aprile 2024.

Per ulteriori informazioni, consultare la locandina allegata, o contattare la Prof.ssa Lucia Anna Stivala (luciaanna.stivala@unipv.it)

Per maggiori informazioni sul seminario, organizzato dalla Fondazione IRCCS Policlinico San Matteo e dall'Univerità di Pavia, vedere la pagina al link sottostante.

Il Dipartimento di Medicina Molecolare è lieto di invitarvi a partecipare al seminario del Seminario del Dott. Felice-Alessio Bava (Stanford University / INSERM), dal titolo:

"From fundamental questions to technology development, and back: a focus on in situ transcriptomics and cancer".

Il semiario avrà luogo presso l'Aula Mosca in via Forlanini 14/16, a partire dalle ore 12 di venerdì 9 febbraio 2024.

Biosketch:

Dr. Bava worked in the laboratory of Prof. Garry Nolan, where he carried out studies in the field of cancer/cancer immunology (Nat. Commun., 2023) and co-developed multiple single-cell and spatial technologies (Nat. Methods 2016, Science 2018, Commun. Biol. 2020, Nat. Commun. 2021). After a brief experience as Principal Investigator at Institut Curie, he decided to join 10x Genomics where he started a team to develop an "in situ transcriptomics" method, recently commercialized under the name of Xenium.
In his seminar, he will discuss how fundamental questions in the field of RNA biology fueled the need of developing new methods that enable co-detection of proteins and RNAs in single-cells by mass-cytometry, and how a sequencer can be used as if it were a cytometer. He will then share how a fundamental question in the field of cancer immunology led him to develop (i) a method for super-resolution imaging of subcellular structures and (ii) “STARmap” an in situ transcriptomics method that enables visualization of 1000s of RNAs in thick tissues. Finally, he will describe what it takes to bring in situ transcriptomics to industry, so that many labs in the world would be able to use it, showcasing its usefulness in the study of tumor-microenvironment.